Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ammonia (NH₃) is a colorless gas with a pungent odor, serving as a fundamental component in biological systems (nitrogen cycle) and various industrial processes (fertilizers, chemical synthesis). While essential in certain biological pathways, elevated levels can be toxic. It is not typically considered a direct therapeutic target, but rather a molecule whose levels are managed in the context of certain diseases.
Lactulose: Acidifies the colon, promoting conversion of ammonia to ammonium, which is then excreted. Rifaximin: Reduces ammonia production by decreasing the number of ammonia-producing bacteria in the gut. Benzoate: Combines with ammonia to form hippurate, which is excreted.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ammonia (NH₃).